Cite
HARVARD Citation
Guigon, A. et al. (2022). Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance. Journal of infection. 84 (2), pp. 248-288. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guigon, A. et al. (2022). Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance. Journal of infection. 84 (2), pp. 248-288. [Online].